Adma Biologics (ADMA) Q3 Earnings Match Estimates

Adma Biologics (ADMA) came out with quarterly earnings of $0.16 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.15 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this infectious disease drug developer would post earnings of $0.14 per share when it actually produced earnings of $0.15, delivering a surprise of +7.14%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.Adma ...